Post

Photopharmics kickstarts phototherapy trial for Parkinson’s disease 

US-based equipment manufacturer Photopharmics has announced the initiation of its ‘Celeste light for PD’ clinical trial investigating the Celeste phototherapy …

Seyltx buys Algernon’s Phase II chronic cough therapy

US-based Seyltx has closed an agreement to acquire Algernon Pharmaceuticals’ chronic cough therapy, ifenprodil (NP-120). Algernon received a purchase price …

Iambic begins dosing in trial of IAM1363 for HER2-driven cancer

Iambic Therapeutics has initiated the dosing of the first subject in its Phase I/Ib clinical trial of IAM1363, a novel …

Immuneering doses first subject in Phase I/IIa solid tumour trial

Immuneering has dosed the first subject in its Phase I/IIa clinical trial of IMM-6-415 for the treatment of advanced solid …

Virion reports safety data from Phase IB HBV immunotherapy trial

Virion Therapeutics has reported encouraging safety outcomes from the first-in-human Phase IB clinical study of VRON-0200, a checkpoint modifier immunotherapy …